Glatiramer acetate (GA, Copolymer-1) an hypothetical treatment option for Rett syndrome

2011 ◽  
Vol 76 (2) ◽  
pp. 190-193 ◽  
Author(s):  
B. Ben-Zeev ◽  
R. Aharoni ◽  
A. Nissenkorn ◽  
R. Arnon
Keyword(s):  
Glatiramer Acetate ◽  
Rett Syndrome ◽  
Treatment Option ◽  
Hypothetical Treatment ◽  
Copolymer 1

Glatiramer acetate (Copolymer-1)-specific, human T cell lines: cytokine profile and suppression of T cell lines reactive against myelin basic protein

2000 ◽  
Vol 289 (3) ◽  
pp. 205-208 ◽  
Author(s):  
Dominik Dabbert ◽  
Sabine Rösner ◽  
Marcus Krämer ◽  
Ulrike Schöll ◽  
Hayrettin Tumani ◽  
...  
Keyword(s):  
T Cell ◽  
Myelin Basic Protein ◽  
Glatiramer Acetate ◽  
Cell Lines ◽  
Basic Protein ◽  
Cytokine Profile ◽  
Human T Cell ◽  
Copolymer 1 ◽  
T Cell Lines ◽  
Acetate Copolymer

Glatiramer acetate is a treatment option in neutralising antibodies to interferon-beta-positive patients

2008 ◽  
Vol 29 (S2) ◽  
pp. 227-229 ◽  
Author(s):  
Marco Capobianco ◽  
Annalisa Rizzo ◽  
Simona Malucchi ◽  
Francesca Sperli ◽  
Alessia Di Sapio ◽  
...  
Keyword(s):  
Glatiramer Acetate ◽  
Treatment Option ◽  
Interferon Beta ◽  
Neutralising Antibodies

Pharmacologic Treatment of Rett Syndrome With Glatiramer Acetate

2016 ◽  
Vol 61 ◽  
pp. 51-57 ◽  
Author(s):  
Aleksandra Djukic ◽  
Roee Holtzer ◽  
Shlomo Shinnar ◽  
Hiren Muzumdar ◽  
Susan A. Rose ◽  
...  
Keyword(s):  
Glatiramer Acetate ◽  
Rett Syndrome ◽  
Pharmacologic Treatment

A Potential Life-Threatening Reaction to Glatiramer Acetate in Rett Syndrome

2017 ◽  
Vol 68 ◽  
pp. 40-43 ◽  
Author(s):  
Andreea Nissenkorn ◽  
Mona Kidon ◽  
Bruria Ben-Zeev
Keyword(s):  
Glatiramer Acetate ◽  
Rett Syndrome ◽  
Life Threatening

OP23 – 2759: Pharmacological treatment of Rett syndrome with glatiramer acetate (Copaxone)

2015 ◽  
Vol 19 ◽  
pp. S8 ◽  
Author(s):  
A. Djukic ◽  
J. Feldman ◽  
H.P. Frey ◽  
J. Jankowski ◽  
R. Holtzer ◽  
...  
Keyword(s):  
Glatiramer Acetate ◽  
Rett Syndrome ◽  
Pharmacological Treatment

scholarly journals Therapeutic strategies in multiple sclerosis. I. Immunotherapy

1999 ◽  
Vol 354 (1390) ◽  
pp. 1697-1710 ◽  
Author(s):  
Reinhard Hohlfeldf
Keyword(s):  
Multiple Sclerosis ◽  
Glatiramer Acetate ◽  
Therapeutic Strategies ◽  
Interferon Β ◽  
Copolymer 1 ◽  
General Aspects ◽  
Experimental Strategies

This review first addresses several general aspects of the immunotherapy of multiple sclerosis. Next, two approved immunomodulatory treatments, interferon–β and copolymer–1 (glatiramer acetate), are reviewed in more detail. Finally, other immunosuppressive therapies and experimental strategies are briefly discussed.

Sign in / Sign up

Export Citation Format

Share Document